4tx0
From Proteopedia
(Difference between revisions)
m (Protected "4tx0" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | ''' | + | ==The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxyethoxy)-3-(2-methoxyethyl)-3,10-diazabicyclo[4.3.1]decan-2-one== |
| + | <StructureSection load='4tx0' size='340' side='right' caption='[[4tx0]], [[Resolution|resolution]] 1.03Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4tx0]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TX0 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TX0 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=384:(1S,5S,6R)-10-[(3,5-DICHLOROPHENYL)SULFONYL]-5-(2-METHOXYETHOXY)-3-(2-METHOXYETHYL)-3,10-DIAZABICYCLO[4.3.1]DECAN-2-ONE'>384</scene></td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tx0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tx0 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tx0 RCSB], [http://www.ebi.ac.uk/pdbsum/4tx0 PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | A stereoselective synthesis of a derivatized bicyclic [4.3.1]decane scaffold based on an acyclic precursor is described. The key steps involve a Pd-catalyzed sp(3)-sp(2) Negishi-coupling, an asymmetric Shi epoxidation, and an intramolecular epoxide opening. Representative derivatives of this novel scaffold were synthesized and found to be potent inhibitors of the psychiatric risk factor FKBP51, which bound to FKBP51 with the intended molecular binding mode. | ||
| - | + | Stereoselective Construction of the 5-Hydroxy Diazabicyclo[4.3.1]decane-2-one Scaffold, a Privileged Motif for FK506-Binding Proteins.,Bischoff M, Sippel C, Bracher A, Hausch F Org Lett. 2014 Oct 17;16(20):5254-7. doi: 10.1021/ol5023195. Epub 2014 Oct 6. PMID:25286062<ref>PMID:25286062</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Peptidylprolyl isomerase]] | ||
| + | [[Category: Bischoff, M.]] | ||
| + | [[Category: Bracher, A.]] | ||
| + | [[Category: Hausch, F.]] | ||
| + | [[Category: Sippel, C.]] | ||
| + | [[Category: Fk-506 binding domain]] | ||
| + | [[Category: Hsp90 cochaperone]] | ||
| + | [[Category: Immunophiline]] | ||
| + | [[Category: Isomerase]] | ||
| + | [[Category: Peptidyl-prolyl isomerase]] | ||
Revision as of 10:43, 20 October 2014
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxyethoxy)-3-(2-methoxyethyl)-3,10-diazabicyclo[4.3.1]decan-2-one
| |||||||||||
